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Etiology of Congenital Heart Disease
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The different factors involved in the etiology of cengenital heart disease are discussed with particular attention lo the teratogenic agents. Experimental
production
of congenital heart disease in animals is reviewed. This seems to be a very promising field for investigations, which may eventually lead to an understanding of the
etiology of congenital heart disease and its prevention.

Research on the etiology of congenital heart disease (CHD) has a
direct bearing on its prevention and
treatment. To appreciate the importance of this, consider that the incidence of CHD in the U.S. and U.K. is
around 0.5% ^ of all births (varying
from 3 to 9/1000 according to different authors). According to these statistics each year in the U.S. more than
20,000 babies are born with CHD.
In the North American continent over
50% of all heart disease in children
is due to CHD. Congenital malformations of the circulatory system account
for roughly half of the mortality from
all congenital malformations.
In discussing the etiological factors
in the genesis of CHD, the possible
causative factors may be divided into
two major groups—(1) the genetic
and (2) the environmental factors.

groups: One consisting of CHD occurring in the genetically distinct syndromes, and the other group consisting
of poorly understood but probably
hereditary types. As yet, no chromosomal defect has been convincingly
identified as producing isolated cardiac
defect. In most instances the cause remains unknown.=
The first group consists of such wellknown chromosomal aberrations as
Down's syndrome. Turner's syndrome,
cri-du-chat syndrome and others.
In a discussion of the etiology of
congenital heart disease, Rainier-Pope^
stated that although Down (who first
described the syndrome named after
him) did not mention the presence of
CHD in his patient, we know that this
syndrome is frequently associated with
CHD. No specific anomaly is associated with Down's syndrome, though
endocardial cushion defect, ostium primum. atrial septal defect (ASD) and
abnormalities of the tricuspid valves
are frequent. Transposition of the great
vessels, infantile coarctation of the aorta and dextrocardia apparently are very
rare.-' ^

Genetic Factors in the Genesis
of CHD
1. Chromosomal defect as an etiological factor in CHD.
The effect of chromosomal defects
can be further divided into two major
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Trisomy 13-15 as well as trisomy 18
are frequently associated with CHD.
Warkany-' et al reported that the major
and the most common cardiac defect
in these trisomies are ventricular septal
defect (VSD) and patent ductus arteriosus (PDA). Trisomy 13-15 is more
frequently associated with ASD, whereas it is comparatively rare in trisomy
18. Trisomy 18 is more frequently associated with VSD and some degree of
aortic dextroposition, coarctation of the
aorta and hypoplastic left ventricle.

2. Hereditary conditions without obvious chromosomal abnormalities.
Marfan's syndrome, Hurler's and
Kartagener's syndromes are associated
with CHD; however, there are no obvious chromosomal abnormalities, at
least with the present methods, in these
conditions.
3. Congenital heart disease with hereditary tendency.
In a review of literature on this
subject Higgins^ concluded that familial aggregation of cases of CHD seems
to be established, with frequency higher in siblings of those afflicted than in
the general population. Also, it appears
to vary with the type of malformation.
One example of a heart disease
which shows a pattern of hereditary
transmission is ASD which may follow
an autosomal dominant type of transmission. There are also cases of isolated families^"' " ' ^- with conduction
defects and arrhythmias. A syndrome
of conduction defect as well as generalized lentigo has been described recently.
Although the sex ratio in CHD does
not differ from expectation,^ certain
malformations such as aortic stenosis,
coarctation and tetralogy of Fallot are
more common in males, and others like
PDA and ASD are more common in
females.
Consanguinity does not seem to be
an important factor,^ although there are
suggestions that the incidence of consanguinity is highest in pulmonary
valvular stenosis and ASD.

The cri-du-chat syndrome,** which is
due to a deletion of the short arm of
chromosome 5, is frequently associated
with CHD. Defects have been noticed
in nine of 33 cases.
Turner's syndrome'- ^' " is frequently
associated with CHD, the most frequent varieties being coarctation of the
aorta, pulmonic stenosis, VSD, ASD
and PDA. In large series it has been
shown to be associated with CHD in
44% of cases.
The majority of patients with Noonan's syndrome,^'" have CHD involving the right side of the heart, particularly pulmonary arterial stenosis or
peripheral pulmonary arterial stenosis.
This is in contradistinction to the Turner's syndrome which is more frequently associated with the lesions of the left
side of the heart, e.g. coarctation of
the aorta or aortic stenosis of valvular
and subaortic type.
If the classical aberrations of chromosomes are included, chromosomal
abnormalities as a cause of CHD may
be estimated at between 3 to 5%.''

Environmental Factors in
the Genesis of CHD
1. Viruses as etiological factor.
Except for rubella and Coxsackie
viruses, investigators have failed to es-

A number of chromosomal abnormalities, such as Klinefelter's and the
triple X syndrome, are not associated
with heart abnormalities.102
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tablish any cause and effect relationship
between viral infections and CHD.
There is a 15% incidence of major
defects after rubella in the first trimester of pregnancy;^'' however, the
figures on congenital anomalies in offspring of these mothers have ranged
from 12 to 90%. Campbell'-'' found
a distribution of lesions as follows:
PDA—58%; VSD—17%; tetralogy of
Fallot—7%; ASD—6%; pulmonic
valvular stenosis—6% ; and miscellaneous—4%. Peripheral pulmonary artery stenosis due to maternal rubella
syndrome is a well-known entity."
Campbell concluded that maternal
rubella is responsible for less than 2%
of cases of C H D . " Myocardial damage'" as evidenced by the presence of
ECG abnormalities, congestive heart
failure, myocardial necrosis and fragmentation of myocardialfibershas also
been reported in cases of maternal rubella syndrome, as has pulmonary valvular insufficiency secondary to rubella
embryopathy.'**
Coxsackie viruses have been suggested as possible causative agents in
the development of CHD.'" Brown et
al- reported that Coxsackie virus B type
3 and 4 were most frequendy associated with malformed infants. Most infections had occurred during the first trimester of pregnancy and the congenital
anomalies observed were PDA, VSD,
ASD, aortic stenosis and atresia.
Mumps-" virus infection during pregnancy has been claimed to be important
in the etiology of endocardial fibroelastosis. This has not been confirmed by
other workers. Higgins' states that despite the predominantiy negative results, further studies would seem indicated on the relation of virus infections
to the development of CHD.
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2. Teratogenic agents in the etiology
of CHD.
In addition to viruses, innumerable
agents can cause congenital abnormalities if administered under special circumstances. Some essential points in
teratology have recently been discussed
by Brent.-' Among the teratogenic
agents-- one should mention ionizing
radiations, vitamin A deficiency and
excess, vitamin D excess, endocrine
preparations such as steroids and antithyroid drugs, cytotoxic drugs, thalidomide, antibiotics, sulphonamides, and
other drugs like dexedrine, and salicylates. The present discussion will center on those drugs or agents which have
been proven to cause CHD under controlled conditions.
1) X-ray as an etiological agent
in CHD.
Wilson--' produced situs inversus and
common atrioventicular canal in rats
who had been subjected to irradiation
on the ninth day of pregnancy.
2) Hypoxia and hypercapnia as
etiological agents in CHD.
This was first reported by Alzamora- ' who demonstrated that the incidence of PDA is 18 times more common in the infants born in regions
4500-5000 meters above the sea level
than in those who are born at the sea
level. This study was done in Peru.
However, this finding has not been
confirmed.Despite this, the teratogenic effect of hypoxia and its relation
with CHD in animals seems to be more
convincing. Baird-" studied by microdissection the hearts of rats conceived
and reared at high altitude and found
cases of PDA and VSD in his animals.
Later Haring^' studied the effect of hypoxia on pregnant rats and produced
5.4% CHD in the experimental ani-
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mals vs 3.2% in the normal control
group. Another study by Clemmer^*
et al confirms this result. Combined
hypoxia and hypercapnia-" seems to be
far more important in the genesis of
CHD than hypoxia alone. Haring's
experiment on rats subjected to these
agents produced 28.1% CHD, compared with 4.5% in the normal control
animals. Thus it seems that, in animals
at least, hypercapnia can produce CHD
when applied at the proper time during
pregnancy.

phenobarbital have been held responsible for the production of the sporadic
cases of Holt-Oram (digitocardiac)
syndrome.
6) Azo dyes as etiologic agents in
CHD.
Azo dyes (Trypan blue)"' ""• have
been extensively studied because of
their teratogenic effects. The varied
CHD thus produced are out of the
scope of this article. It is of interest,
however, that trypan blue exerts its
effects both by systemic and local application.

3) Steroids as etiological agent in
CHD.
Cortisone is a well-established teratogenic agent in animals and also probably in man. Investigations of its effect on the development of CHD are
few. Clavert et al'*" produced ASD,
VSD and other abnormalities by injection of dexamethasone phosphate in
rabbits during pregnancy.

7) Miscellaneous factors.
Isolated reports in the literature allude to the possible effect of pesticides-'''' in the genesis of CHD in man.
Dexamphetamine sulfate, a drug usually taken during pregnancy to suppress
appetite, has been incriminated. Experimental production of CHD in mice
has been very successful by intraperitoneal injection of this drug.^" However,
the dose administered to the mice was
far beyond the usual therapeutic dose.
Investigating the effect of high temperature on the development of CHD
in chick embryos, De la Cruz-''' thought
that the teratogenic effects of viral infections was secondary to fever. Their
investigation showed, however, that
high temperature does not produce
CHD in chicks—but incubation of eggs
at low temperature produced a 21.8%
incidence of CHD, mostly high membranous VSD.
The study of teratogenic agents in
relation to CHD is extremely important
if one considers that maternal exposure
to potential teratogens is very common.
Nora-*** et al reported that in their survey of 240 mothers, each mother had
been exposed to 3.7 teratogenic agents

4) Thalidomide as an etiologic
agent in CHD.
Besides other abnormalities in man,
thalidomide has produced CHD such
as hypoplasia of aorta, ASD and VSD,
transposition of the great vessels,
tetralogy of Fallot and pulmonary
stenosis.'' '^' -' A syndrome of anotia
or microtia, facial palsy and CHD'*'
(but without phocomelia) has also
been reported—due to thalidomide ingestion during pregnancy.
5) Anticonvulsants as etiologic
agents in CHD.
Anticonvulsant drugs such as primidone, phenytoin, toxidone and phenobarbital are among possible teratogenic
agents. This effect is suspected to be
secondary to folic acid deficiency produced by these drugs.3- Hydantoin and
104
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(3.1 drugs per mother) during the first
trimester of pregnancy. Comparative
studies of CHD in animals can elucidate the pathogenesis of CHD in man.
Although extrapolation of the results is
not easy, it has important bearing on

our understanding of the pathogenesis
of the disease.
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